ApoA-I(Milano)/phospholipid complex: clinical implications of dose-response studies in rabbit atherosclerosis with intravascular ultrasound and magnetic resonance imaging.

[1]  Gemma Vilahur,et al.  Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. , 2008, Journal of the American College of Cardiology.

[2]  C. Sirtori,et al.  Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging. , 2008, Journal of the American College of Cardiology.

[3]  G. Franceschini,et al.  Normal Vascular Function Despite Low Levels of High-Density Lipoprotein Cholesterol in Carriers of the Apolipoprotein A-IMilano Mutant , 2007, Circulation.

[4]  S. Reddy,et al.  Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides Published, JLR Papers in Press, June 14, 2007. , 2007, Journal of Lipid Research.

[5]  P. Barter,et al.  Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits , 2005, Circulation.

[6]  A. Gotto,et al.  A Randomized Trial of a Strategy for Increasing High-Density Lipoprotein Cholesterol Levels: Effects on Progression of Coronary Heart Disease and Clinical Events , 2005, Annals of Internal Medicine.

[7]  A. Skene,et al.  Comparison of intensive and moderate lipid lowering with statins after acute coronary symptoms , 2004 .

[8]  J. Vermillion,et al.  Hemispheric Arteriovenous Malformation , 2004 .

[9]  V. Fuster,et al.  The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging. , 2004, Journal of the American College of Cardiology.

[10]  Paul Schoenhagen,et al.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[11]  Chun Yuan,et al.  Classification of Human Carotid Atherosclerotic Lesions With In Vivo Multicontrast Magnetic Resonance Imaging , 2002, Circulation.

[12]  C. Di Mario,et al.  Recombinant Apolipoprotein A-IMilano Infusion Into Rabbit Carotid Artery Rapidly Removes Lipid From Fatty Streaks , 2002, Circulation research.

[13]  E. Bolson,et al.  Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. , 2001, The New England journal of medicine.

[14]  G. Franceschini,et al.  Cardiovascular Status of Carriers of the Apolipoprotein A-IMilano Mutant: The Limone sul Garda Study , 2001, Circulation.

[15]  Michael F. Oliver,et al.  Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study. , 2001, Indian heart journal.

[16]  J. Gamble,et al.  Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. , 2000, Journal of lipid research.

[17]  C. Di Mario,et al.  Development of a lipid-rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound. , 2000, Atherosclerosis.

[18]  V. Fuster,et al.  The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[19]  B. G. Brown,et al.  Very intensive lipid therapy with lovastatin, niacin, and colestipol for prevention of death and myocardial infarction A 10-year Familial Atherosclerosis Treatment Study follow-up , 1998 .

[20]  V. Fuster,et al.  Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.

[21]  M. Davies,et al.  Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. , 1993, British heart journal.

[22]  J J Albers,et al.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.

[23]  W. Roberts,et al.  Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest. , 1990, The American journal of cardiology.

[24]  R. Mahley,et al.  Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. , 1983, The Journal of biological chemistry.